000			02283cam a2200349 a 4500
003			EG-GiCUC
005			20250223031353.0
008			151212s2015 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.12.02.Ph.D.2015.He.B
100	0		_aHend Gaber Badawy Ibrahym
245	1	0	_aBiochemical studies of some diagnostic enzymes in patients with liver and kidney diseases / _cHend Gaber Badawy Ibrahym ; Supervised Mohamed O. I. Refaie , Sanaa Osman Abdalaa , Mohamed Ali Eldesouky
246	1	5	_aدراسات كيميائية حيوية عن بعض الأنزيمات التشخيصية فى مرضى الكلى و الكبد
260			_aCairo : _bHend Gaber Badawy Ibrahym , _c2015
300			_a167 P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry
520			_aThis work has been carried out to evaluate, the role of Interleukin 2 (IL-2), Interleukin 4 (IL-4), Interleukin 6 (IL-6), Interleukin 8 (IL-8), Glutathione (GSH), Malondialdehyde (MDA), Superoxide dismutase (SOD) Glutamate dehydrogenase (GLDH) and Interferon-Þ (IFN-Þ); in control & for patients suffering from chronic renal failure (CRF) and receiving a regular hemodialysis treatment, also group of patients with liver disease (HCV), in addition patients with (CRF) combined with liver diseases (HCV). Finally all the experimental results evaluated and tabulated statistically Analyzed. Conclusion: IL-2, IL-4, IL-6, IL-8, GSH, MDA, SOD, GLDH and IFN-Þ can be consider good diagnostic parameters in patients suffering from chronic renal failure (CRF), patients with liver disease and also for patients with (CRF) combined with liver disease.
530			_aIssued also as CD
653		4	_aGlutamate dehydrogenase
653		4	_aGlutation,Superoxid dismutase, Malonaldehyde
653		4	_aInrtleukins 2,4,6,8,
700	0		_aMohamed Ali Eldesouky , _eSupervisor
700	0		_aMohamed Osman Ibrahem Refaie , _eSupervisor
700	0		_aSanaa Osman Abdalaa , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSoheir _eCataloger
942			_2ddc _cTH
999			_c53905 _d53905